Dr Reddys Laboratories (RDY) Non-Current Assets (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Non-Current Assets of $3.0 billion for Q1 2026, up 3.94% year-over-year from $2.8 billion in Q1 2025, and up 3.94% quarter-over-quarter from $2.8 billion in Q1 2025.
Dr Reddys Laboratories (RDY) Non-Current Assets (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Non-Current Assets history runs 10 years deep, the most recent figure standing at $3.0 billion for Q1 2026.
- In Q1 2026, Non-Current Assets rose 3.94% year-over-year to $3.0 billion; the TTM figure through Mar 2026 stood at $8.9 billion (up 20.23% YoY), while the FY2026 annual figure was $3.0 billion, up 3.94% from the prior year.
- Non-Current Assets for Q1 2026 stood at $3.0 billion, up from $2.8 billion in the prior quarter.
- The five-year high for Non-Current Assets was $3.0 billion in Q1 2026, with the low at $1.4 billion in Q1 2023.
- The 5-year median for Non-Current Assets is $1.7 billion (2024), against an average of $2.1 billion.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets dropped 8.73% in 2022, then surged 69.89% in 2025.
- Dr Reddys Laboratories' Non-Current Assets stood at $1.5 billion in 2022, then dropped by 4.44% to $1.4 billion in 2023, then advanced by 19.74% to $1.7 billion in 2024, then soared by 69.89% to $2.8 billion in 2025, then grew by 3.94% to $3.0 billion in 2026.
- Business Quant data shows RDY's Non-Current Assets at $3.0 billion in Q1 2026, $2.8 billion in Q1 2025, and $1.7 billion in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 2.96 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 2.87 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.96 Bn |
| Mar 31, 2025 | 2.84 Bn |
| Mar 31, 2024 | 1.67 Bn |
| Mar 31, 2023 | 1.40 Bn |
| Mar 31, 2022 | 1.46 Bn |
| Mar 31, 2021 | 1.60 Bn |
| Mar 31, 2020 | 1.35 Bn |
| Mar 31, 2019 | 1.60 Bn |
| Mar 31, 2018 | 1.78 Bn |
| Dec 31, 2009 | 761.00 Mn |
| Sep 30, 2009 | 934.00 Mn |
| Jun 30, 2009 | 937.00 Mn |